AlphaMark Advisors’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

AlphaMark Advisors’s Portfolio FOMX Stock Details FOMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-3,050	Closed	-$10K	–	634
2019 Q4	$10K	Buy	3,050 +1,240	+69%	+$3.94K	﹤0.01%	333
2019 Q3	$6K	Hold	1,810	–	–	﹤0.01%	388
2019 Q2	$4K	Hold	1,810	–	–	﹤0.01%	445
2019 Q1	$7K	Buy	+1,810	New	+$6.78K	﹤0.01%	369

AlphaMark Advisors's FOMX Position: Q1 2020 in Review

AlphaMark Advisors sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q1 2020, closing a stake of 3,050 shares — an estimated $10K sold.

AlphaMark Advisors first reported a position in FOMX in Q1 2019 and held it in 4 quarters. The position peaked at $10K in Q4 2019. 3 funds tracked by Wall St. Rank hold FOMX as of Q1 2020.

AlphaMark Advisors reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q1 2020 after selling out during the quarter.
AlphaMark Advisors sold 3,050 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q1 2020, an estimated $10K.
AlphaMark Advisors first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q1 2019 and held it in 4 quarters.
AlphaMark Advisors's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $10K in Q4 2019.
3 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q1 2020.

Based on AlphaMark Advisors's 13F filing for Q1 2020, filed 24 Apr 2020.